Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.1B | 1.4B | 1.5B |
Cost of revenue | 1.1B | 999M | 1.3B | 1.4B |
Gross profit | 99M | 85M | 105M | 129M |
Operating expense | ||||
Research & development | 21M | 33M | 30M | 37M |
Selling general and admin | 131M | 129M | 142M | 164M |
Other operating expenses | — | — | — | — |
Operating income | -53M | -77M | -67M | -72M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 33M | 32M | 34M | 30M |
Other income expense | 1M | -4M | 23M | 11M |
Pretax income | -85M | -113M | -78M | -91M |
Tax provision | 0 | 0 | 0 | 1M |
Net income | -85M | -113M | -78M | -92M |
Basic EPS | -0.1 | -0.2 | -0.1 | -0.1 |
Diluted EPS | -0.1 | -0.2 | -0.1 | -0.1 |
Basic average shares | 723.5M | 716.3M | 705.4M | 693.4M |
Diluted average shares | 723.5M | 716.3M | 705.4M | 693.4M |
EBITDA | -38M | -51M | -32M | -47M |
Net income from continuing op. | -85M | -113M | -78M | -92M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |